Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer
Public ClinicalTrials.gov record NCT03233555. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Extended Cancer Education for Longer-Term Survivors (EXCELS) In Primary Care
Study identification
- NCT ID
- NCT03233555
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Rutgers, The State University of New Jersey
- Other
- Enrollment
- 535 participants
Conditions and interventions
Conditions
- Stage I Breast Cancer
- Stage I Colorectal Cancer AJCC v6 and v7
- Stage I Prostate Cancer
- Stage IA Breast Cancer
- Stage IB Breast Cancer
- Stage II Breast Cancer
- Stage II Colorectal Cancer AJCC v7
- Stage II Prostate Cancer
- Stage IIA Breast Cancer
- Stage IIA Colorectal Cancer AJCC v7
- Stage IIA Prostate Cancer
- Stage IIB Breast Cancer
- Stage IIB Colorectal Cancer AJCC v7
- Stage IIB Prostate Cancer
- Stage IIC Colorectal Cancer AJCC v7
- Stage III Colorectal Cancer AJCC v7
- Stage IIIA Colorectal Cancer AJCC v7
- Stage IIIB Colorectal Cancer AJCC v7
- Stage IIIC Colorectal Cancer AJCC v7
Interventions
- Informational Intervention Other
- Internet-Based Intervention Other
- Quality-of-Life Assessment Other
- Questionnaire Administration Other
- Telephone-Based Intervention Behavioral
Other · Behavioral
Eligibility (public fields only)
- Age range
- 30 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2, 2013
- Primary completion
- Jan 14, 2020
- Completion
- Jul 30, 2022
- Last update posted
- Aug 28, 2022
2013 – 2022
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03233555, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 28, 2022 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03233555 live on ClinicalTrials.gov.